Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Outcome Measure:

anti hepatitis B antibodies

Outcome Time Frame:

3 month

Safety Issue:

No

Authority:

Israel: Ministry of Health

Study ID:

3097

NCT ID:

NCT00863187

Start Date:

February 2009

Completion Date:

Related Keywords:

• Lymphoma
• Lymphoma